Cargando…
Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report
RATIONALE: Nephrogenic diabetes insipidus (NDI) rarely presents in the initial stage of acute lymphoblastic leukemia (ALL) and relapse due to renal infiltration is also rare. PATIENT CONCERNS: A 19-year-old man presented with weakness, polydipsia, and polyuria for 1 month. DIAGNOSES: NDI was diagnos...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024069/ https://www.ncbi.nlm.nih.gov/pubmed/29901649 http://dx.doi.org/10.1097/MD.0000000000011157 |
_version_ | 1783335988234289152 |
---|---|
author | Li, Dezhi Liu, Qian Feng, Zhifang Zhang, Qi Feng, Saran |
author_facet | Li, Dezhi Liu, Qian Feng, Zhifang Zhang, Qi Feng, Saran |
author_sort | Li, Dezhi |
collection | PubMed |
description | RATIONALE: Nephrogenic diabetes insipidus (NDI) rarely presents in the initial stage of acute lymphoblastic leukemia (ALL) and relapse due to renal infiltration is also rare. PATIENT CONCERNS: A 19-year-old man presented with weakness, polydipsia, and polyuria for 1 month. DIAGNOSES: NDI was diagnosed with insignificant response to a water deprivation test after stimulation with vasopressin injection. Bone marrow examination combined with immunophenotypic analysis, cerebrospinal cytology, and abdominal ultrasonography confirmed the diagnoses of precursor B cell ALL with renal infiltration. INTERVENTIONS: The patient accepted standardized combination chemotherapy and ultimately had sustained remission, and his polydipsia and polyuria disappeared after 3 days of treatment. The ALL relapsed 1 year later and he received haploidentical stem cell transplantation (haplo-SCT) from his father. OUTCOMES: One year later, he again developed NDI, with bilateral renal enlargement because of extramedullary relapse, leading to subsequent death. LESSONS: This case demonstrates unusual early renal involvement in ALL presenting with initial NDI. Interestingly, the NDI returned with the relapse of renal infiltration 1 year after haplo-SCT. This case suggests that NDI was probably secondary to renal leukemic infiltration. |
format | Online Article Text |
id | pubmed-6024069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-60240692018-07-03 Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report Li, Dezhi Liu, Qian Feng, Zhifang Zhang, Qi Feng, Saran Medicine (Baltimore) Research Article RATIONALE: Nephrogenic diabetes insipidus (NDI) rarely presents in the initial stage of acute lymphoblastic leukemia (ALL) and relapse due to renal infiltration is also rare. PATIENT CONCERNS: A 19-year-old man presented with weakness, polydipsia, and polyuria for 1 month. DIAGNOSES: NDI was diagnosed with insignificant response to a water deprivation test after stimulation with vasopressin injection. Bone marrow examination combined with immunophenotypic analysis, cerebrospinal cytology, and abdominal ultrasonography confirmed the diagnoses of precursor B cell ALL with renal infiltration. INTERVENTIONS: The patient accepted standardized combination chemotherapy and ultimately had sustained remission, and his polydipsia and polyuria disappeared after 3 days of treatment. The ALL relapsed 1 year later and he received haploidentical stem cell transplantation (haplo-SCT) from his father. OUTCOMES: One year later, he again developed NDI, with bilateral renal enlargement because of extramedullary relapse, leading to subsequent death. LESSONS: This case demonstrates unusual early renal involvement in ALL presenting with initial NDI. Interestingly, the NDI returned with the relapse of renal infiltration 1 year after haplo-SCT. This case suggests that NDI was probably secondary to renal leukemic infiltration. Wolters Kluwer Health 2018-06-15 /pmc/articles/PMC6024069/ /pubmed/29901649 http://dx.doi.org/10.1097/MD.0000000000011157 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | Research Article Li, Dezhi Liu, Qian Feng, Zhifang Zhang, Qi Feng, Saran Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report |
title | Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report |
title_full | Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report |
title_fullStr | Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report |
title_full_unstemmed | Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report |
title_short | Nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: A case report |
title_sort | nephrogenic diabetes insipidus in initial stage of acute lymphoblastic leukemia and relapse after haploidentical hematopoietic stem-cell transplantation: a case report |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024069/ https://www.ncbi.nlm.nih.gov/pubmed/29901649 http://dx.doi.org/10.1097/MD.0000000000011157 |
work_keys_str_mv | AT lidezhi nephrogenicdiabetesinsipidusininitialstageofacutelymphoblasticleukemiaandrelapseafterhaploidenticalhematopoieticstemcelltransplantationacasereport AT liuqian nephrogenicdiabetesinsipidusininitialstageofacutelymphoblasticleukemiaandrelapseafterhaploidenticalhematopoieticstemcelltransplantationacasereport AT fengzhifang nephrogenicdiabetesinsipidusininitialstageofacutelymphoblasticleukemiaandrelapseafterhaploidenticalhematopoieticstemcelltransplantationacasereport AT zhangqi nephrogenicdiabetesinsipidusininitialstageofacutelymphoblasticleukemiaandrelapseafterhaploidenticalhematopoieticstemcelltransplantationacasereport AT fengsaran nephrogenicdiabetesinsipidusininitialstageofacutelymphoblasticleukemiaandrelapseafterhaploidenticalhematopoieticstemcelltransplantationacasereport |